Day -1 CD34+ Cells and Platelet Count Predict the Number of Apheresis in Poor-Mobilizer Patients Rescued by Plerixafor

Plerixafor is widely used as up-front treatment with G-CSF to enhance peripheral blood hematopoietic stem cell output in patients failing previous mobilizations. Less frequently, plerixafor is used to rescue an unsatisfactory mobilization following chemotherapy (CT) and G-CSF. This study investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Valentini, Caterina Giovanna, Pellegrino, Claudio, Putzulu, Rossana, Bonanni, Matteo, Massini, Giuseppina, Orlando, Nicoletta, Forni, Franca, Bianchi, Maria, Piccirillo, Nicola, Teofili, Luciana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866585/
https://www.ncbi.nlm.nih.gov/pubmed/36675546
http://dx.doi.org/10.3390/jcm12020618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866585/
https://www.ncbi.nlm.nih.gov/pubmed/36675546
http://dx.doi.org/10.3390/jcm12020618

Ejemplares similares